A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions
Public ClinicalTrials.gov record NCT02395042. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study, Evaluating Safety and Efficacy of LiRIS® 400 mg in Females With Interstitial Cystitis With Hunner's Lesions
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a safety and efficacy study of LiRIS® in females with interstitial cystitis with Hunner's lesions.
Study identification
- NCT ID
- NCT02395042
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 14, 2015
- Primary completion
- Jun 28, 2017
- Completion
- Nov 19, 2017
- Last update posted
- Oct 4, 2018
2015 – 2017
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tri Valley Urology Medical Group | Murrieta | California | 92562 | — |
| Sutter Institute for Medical Research | Vacaville | California | 95688 | — |
| Women's Health Specialty Care | Farmington | Connecticut | 06032 | — |
| Atlanta Medical Research Institute | Alpharetta | Georgia | 30005 | — |
| Anne Arundel Urology, P.A. | Annapolis | Maryland | 21401 | — |
| Chesapeake Urology Research Associates | Baltimore | Maryland | 21237 | — |
| Beyer Research | Kalamazoo | Michigan | 49009 | — |
| Beaumont Health System | Royal Oak | Michigan | 48073 | — |
| Washington University School of Medicine Department of Surgery | St Louis | Missouri | 63110 | — |
| Western New York Urology Associates, LLC | Cheektowaga | New York | 14214 | — |
| McKay Urology | Charlotte | North Carolina | 28207 | — |
| Eastern Urological Associates, PA | Greenville | North Carolina | 27834 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27103 | — |
| MetroHealth System/Center for Advanced Gynecology | Cleveland | Ohio | 44109 | — |
| Philadelphia Urosurgical Associates | Philadelphia | Pennsylvania | 19107 | — |
| University of Washington | Seattle | Washington | 98195 | — |
| Aurora Health Care | West Allis | Wisconsin | 53227 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02395042, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 4, 2018 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02395042 live on ClinicalTrials.gov.